Company Profile LogoInversago Pharma

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists

Edit IconSuggest an Edit
Biopharma
Pharmaceutical
Medical
Health Care
Biotechnology

    Unlock insights on Inversago Pharma and 2M+ companies now!

    About Inversago Pharma

    Located in Montreal, Inversago Pharma is a privately owned Canadian biotech company at clinical-stage, specialized in the development of new therapies focusing on CB1 blockade, based on first-in-class, peripherally-acting, CB1 inverse agonists. The Company aims to provide new treatment options that improve the lives of patients affected by metabolic conditions such as Diabetic Kidney Disease (DKD), including Diabetic Nephropathy (DN), Type 1 and Type 2 Diabetes (T1D / T2D) Non-Alcoholic Steatohe

    Company Highlights
    Year Founded

    2015

    icon-altStatus

    Acquired

    icon-altEmployees

    21

    Location (HQ)

    CAN

    Since Last Funding

    1 year 10 months

    Monthly Website Visitors

    10.8K

    icon-altTotal Investment Amt

    $100M

    icon-altYoY Headcount Growth

    -24.91%

    Key Metrics

    Senior Hires

    NameLinkedin ProfilePositionDate Joined
    John Doehttps://www.linkedin.com/in/johndoeCEOCEO
    Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
    John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
    Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
    Get API access to complete private company database with growth metrics from 15 sources

    Similar Companies

    Medical

    Health Care

    Biotechnology

    Biotechnology Research

    Pharmaceutical

    Pharmaceuticals

    Biopharma